Site Sponsors
  • Oxford Instruments Nanoanalysis - X-Max Large Area Analytical EDS SDD
  • Strem Chemicals - Nanomaterials for R&D
  • Park Systems - Manufacturer of a complete range of AFM solutions
  • 20% off Mass Spectrometer range at Conquer Scientific

Webinar On Malvern's Biopharmaceutical Analytical Toolkit Now Available to Watch Online

Published on April 11, 2013 at 6:20 AM

A recent Malvern Instruments sponsored webinar, presented by specialists from the company, examined the need for specific analytical tools for biopharmaceutical applications. The recording of the live event, which attracted more than 600 registrants, is now available to view online.

In the presentation, Mark Pothecary and Paul Clarke, Product Manager and Product Group Manager respectively for Nanoparticle and Molecular Characterization at Malvern Instruments, discuss a variety of the analytical technologies that are available for the growing biopharmaceutical industry.

They provide fresh insights into the use of a number of well-established characterization techniques, including light scattering and size exclusion chromatography (GPC/SEC) and illustrate the use of these techniques in combination, showing how they can provide a wide range of complementary information useful to protein scientists.

The continued shift within the industry towards biopharmaceuticals has resulted in the need for analytical instrumentation that can quickly deliver compelling solutions to meet rapidly evolving analytical and regulatory challenges. In particular the move towards drugs using biomolecules as the active has stimulated advances in new analytical procedures.

As well as traditional techniques, such as GPC/SEC and dynamic light scattering (DLS), which can be performed separately or in combination (SEC-DLS), new technologies including microrheology and resonant mass measurement are rapidly becoming essential components of the analytical toolkit.

Within Malvern Instruments, the company’s global Bioscience Development Initiative recognizes the unprecedented pace of development in biopharmaceuticals and the onus this places on analytical instrumentation companies to quickly deliver solutions to a host of rapidly evolving analytical and regulatory challenges.

Malvern’s Bioscience Development Initiative is focused specifically on the requirements of the biopharmaceutical sector, most notably the biochemical and biophysical characterization needs relating to formulation and product development.

You can view the webinar here, or contact Malvern Instruments for more information.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit